Pyridazinones as PARP7 inhibtors

The present invention relates to pyridazinones and related compounds having Formula I:and pharmaceutically acceptable salts thereof, which are inhibitors of PARP7 and are useful in the treatment of cancer.

Saved in:
Bibliographic Details
Main Authors Kuntz, Kevin Wayne, Perl, Nicholas Robert, Vasbinder, Melissa Marie
Format Patent
LanguageEnglish
Published 04.07.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to pyridazinones and related compounds having Formula I:and pharmaceutically acceptable salts thereof, which are inhibitors of PARP7 and are useful in the treatment of cancer.
Bibliography:Application Number: US202017083442